TY - JOUR
T1 - Case Report
T2 - Infantile-Onset Fulminant Type 1 Diabetes Mellitus Caused by Novel Compound Heterozygous LRBA Variants
AU - Totsune, Eriko
AU - Nakano, Tomohiro
AU - Moriya, Kunihiko
AU - Sato, Daichi
AU - Suzuki, Dai
AU - Miura, Akinobu
AU - Katayama, Saori
AU - Niizuma, Hidetaka
AU - Kanno, Junko
AU - van Zelm, Menno C.
AU - Imai, Kohsuke
AU - Kanegane, Hirokazu
AU - Sasahara, Yoji
AU - Kure, Shigeo
N1 - Funding Information:
KM was supported by grant from the Japanese Ministry of Health, Labor and Welfare of Japan (Grant Number 19K23819). MZ was supported by the Australian National Health and Medical Research Council (NHMRC; Senior Research Fellowship 1117687) and the Jeffrey Modell Foundation.
Publisher Copyright:
© Copyright © 2021 Totsune, Nakano, Moriya, Sato, Suzuki, Miura, Katayama, Niizuma, Kanno, van Zelm, Imai, Kanegane, Sasahara and Kure.
PY - 2021/4/12
Y1 - 2021/4/12
N2 - Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was LRBA. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the LRBA gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.
AB - Lipopolysaccharide-responsive beige-like anchor (LRBA) deficiency is a subtype of common variable immune deficiency (CVID). Numerous case reports and cohort studies have described a broad spectrum of clinical manifestations and variable disease phenotypes, including immune dysregulation, enteropathy, and recurrent infections. Although LRBA deficiency is an autosomal recessive primary immunodeficiency resulting in a phenotype similar to CVID, it is a monogenic disease and separate from CVID. Recently, in a report of monogenic primary immunodeficiency disorder associated with CVID and autoimmunity, the most common mutated gene was LRBA. We report the case of a girl who presented with fulminant type 1 diabetes at age 7 months. She later experienced recurrent bacterial infections with neutropenia and idiopathic thrombocytopenic purpura. Clinical genome sequencing revealed compound heterozygosity of the LRBA gene, which bore two novel mutations. A genetic basis should be considered in the differential diagnosis for very young patients with fulminant autoimmunity, and the diagnostic work-up should include evaluation of markers of immunodeficiency.
KW - CTLA-4 deficiency
KW - infantile-onset fulminant type 1 diabetes mellitus
KW - LRBA deficiency
KW - refractory autoimmune cytopenia
KW - transposable elements (TE)
UR - http://www.scopus.com/inward/record.url?scp=85104998161&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104998161&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.677572
DO - 10.3389/fimmu.2021.677572
M3 - Article
C2 - 33912197
AN - SCOPUS:85104998161
SN - 1664-3224
VL - 12
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 677572
ER -